News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
892,570 Results
Type
Article (89400)
Company Profile (566)
Press Release (802573)
Multimedia
Podcasts (270)
Webinars (42)
Section
Business (267334)
Career Advice (4174)
Deals (40108)
Drug Delivery (217)
Drug Development (92002)
Employer Resources (211)
FDA (18697)
Job Trends (17537)
News (399358)
Policy (40037)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (2)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (10)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (5)
2027 Genetown Standard (11)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (9)
Academia (3093)
Academic (2)
Accelerated approval (70)
ADA (51)
Adcomms (44)
Allergies (224)
Alliances (56996)
ALS (272)
Alzheimer's disease (2098)
Antibody-drug conjugate (ADC) (680)
Approvals (19209)
Artificial intelligence (1059)
ASCO (345)
Autoimmune disease (452)
Automation (78)
Bankruptcy (412)
Belgium (13)
Best Places to Work (12636)
BIO (81)
Biologics (25)
BIOSECURE Act (23)
Biosimilars (290)
BioSpace Insights (256)
Biotechnology (341)
Bispecific (6)
Bladder cancer (232)
Brain cancer (98)
Breast cancer (920)
Cancer (7432)
Cardiovascular disease (644)
Career advice (3629)
Career pathing (63)
CAR-T (428)
CDC (78)
CDMO (193)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (1189)
Cervical cancer (62)
Clinical research (80331)
Collaboration (2713)
Commercialization (16)
Company closure (10)
Compensation (1797)
Complete response letters (124)
COVID-19 (3064)
CRISPR (139)
C-suite (1604)
Cystic fibrosis (179)
Data (9934)
Decentralized trials (3)
Denatured (106)
Depression (222)
Dermatology (148)
Diabetes (796)
Diagnostics (7834)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (530)
Drug pricing (252)
Drug shortages (39)
Duchenne muscular dystrophy (370)
Earnings (103736)
Editorial (84)
Employer branding (27)
Employer resources (182)
Events (140334)
Executive appointments (1339)
Eye disease (3)
FDA (23502)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (26)
Frontotemporal dementia (39)
Funding (2243)
Gene editing (299)
Generative AI (107)
Gene therapy (936)
GLP-1 (1362)
Government (5610)
Grass and pollen (8)
Guidances (436)
Healthcare (21397)
Hematology (198)
HIV (116)
Huntington's disease (79)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (138)
Immunology and inflammation (410)
Immuno-oncology (142)
Indications (259)
Infectious disease (3496)
Inflammatory bowel disease (256)
Inflation Reduction Act (17)
Influenza (160)
Intellectual property (369)
Interviews (828)
IPO (18049)
IRA (61)
Job creations (5211)
Job search strategy (2881)
JPM (73)
Kidney cancer (29)
Kidney disease (101)
Labor market (141)
Layoffs (714)
Leadership (65)
Legal (10177)
Licensing (43)
Liver cancer (116)
Longevity (50)
Lung cancer (1022)
Lymphoma (528)
Machine learning (75)
Management (71)
Manufacturing (1529)
Marketing (14)
MASH (241)
Medical affairs (3)
Medical device (15434)
Medtech (15713)
Mergers & acquisitions (23535)
Metabolic disorders (2032)
mRNA (316)
Multiple sclerosis (233)
Multispecific (1)
NASH (24)
Netherlands (11)
Neurodegenerative disease (589)
Neuropsychiatric disorders (149)
Neuroscience (4132)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5165)
Now hiring (97)
Obesity (964)
Opinion (398)
Ovarian cancer (268)
Pain (324)
Pancreatic cancer (415)
Parkinson's disease (466)
Partnered (50)
Patents (774)
Patient advocacy (1)
Patient recruitment (960)
Patient selection (28)
Peanut (76)
People (68812)
Peptides (10)
Pharmaceutical (82)
Pharmacy benefit managers (40)
Phase 1 (24775)
Phase 2 (34850)
Phase 3 (26292)
Pipeline (12727)
Policy (418)
Postmarket research (3561)
Preclinical (11084)
Press Release (72)
Prostate cancer (384)
Psychedelics (95)
Radioligand (1)
Radiopharmaceuticals (424)
Rare diseases (1505)
Real estate (7475)
Recruiting (83)
Regenerative medicine (11)
Regulatory (31488)
Reports (95)
Research institute (2805)
Resumes & cover letters (656)
Rett syndrome (53)
RNA editing (34)
RSV (102)
Schizophrenia (213)
Series A (390)
Series B (274)
Service/supplier (16)
Sickle cell disease (140)
Special edition (36)
Spinal muscular atrophy (199)
Sponsored (59)
Startups (4394)
State (2)
Stem cells (1)
Stomach cancer (22)
Substance use disorders (21)
Supply chain (161)
Tariffs (105)
The Weekly (161)
Vaccines (1395)
Venture capital (166)
Weight loss (648)
Wet AMD (1)
Women's health (172)
Worklife (27)
Date
Today (139)
Last 7 days (637)
Last 30 days (2857)
Last 365 days (33638)
2026 (25195)
2025 (33214)
2024 (37867)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1303)
Alabama (115)
Alaska (7)
Arizona (463)
Arkansas (16)
Asia (52893)
Australia (9307)
California (16147)
Canada (4512)
China (1890)
Colorado (695)
Connecticut (723)
Delaware (500)
Europe (122043)
Florida (2467)
Georgia (524)
Hawaii (5)
Idaho (70)
Illinois (1410)
India (137)
Indiana (737)
Iowa (31)
Japan (722)
Kansas (155)
Kentucky (67)
Louisiana (68)
Maine (95)
Maryland (1928)
Massachusetts (11715)
Michigan (457)
Minnesota (892)
Mississippi (7)
Missouri (181)
Montana (37)
Nebraska (31)
Nevada (180)
New Hampshire (92)
New Jersey (4268)
New Mexico (38)
New York (4234)
North Carolina (2114)
North Dakota (12)
Northern California (8161)
Ohio (517)
Oklahoma (31)
Oregon (51)
Pennsylvania (3098)
Puerto Rico (37)
Rhode Island (58)
South America (1672)
South Carolina (98)
South Dakota (2)
Southern California (6412)
Tennessee (268)
Texas (2672)
United States (57454)
Utah (490)
Vermont (2)
Virginia (409)
Washington D.C. (89)
Washington State (1304)
West Virginia (4)
Wisconsin (185)
Wyoming (5)
There are 892,570 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Announces First Patient Dosed in BLAZE Investigator-Initiated Trial
October 1, 2026
·
6 min read
Press Releases
Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
October 1, 2026
·
9 min read
Press Releases
Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD
October 1, 2026
·
3 min read
Press Releases
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
October 1, 2026
·
8 min read
Insights
The race for access: How the FAIR Act could reclaim U.S. biotech leadership
In this episode of Denatured, you’ll hear from Max Bronstein, CEO of Aviva Strategies and Teresa Barnes, Chief Executive Warrior of PF Warriors. We dig into why U.S. patients are losing access to rare disease trials happening abroad and how the FAIR Act’s accelerated, harmonized reviews could help the U.S. keep pace while getting lifesaving studies to patients faster.
October 1, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Genentech’s Giredestrant Combination Significantly Improved Progression-Free Survival in ER-positive Advanced Breast Cancer in Phase III evERA Data Published in The New England Journal of Medicine
October 1, 2026
·
8 min read
Press Releases
Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion
October 1, 2026
·
3 min read
Press Releases
Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
October 1, 2026
·
17 min read
Press Releases
Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
October 1, 2026
·
13 min read
Press Releases
IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®
October 1, 2026
·
3 min read
1 of 89,257
Next
